Research / CW / Fundamental state Inspectable configuration
State dimensions Filing 0000026324-22-000012 General Corporate
Debt relative to revenue 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
209.17% · OPTIONAL · VALID
Capex intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.95% · OPTIONAL · VALID
Operating cash generation 5th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-22.22% · OPTIONAL · VALID
Revenue growth 10th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-6.30% · CORE · VALID
Inventory pressure 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
80.10% · OPTIONAL · VALID
Gross margin 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
36.00% · CORE · VALID
Operating margin 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
10.82% · CORE · VALID
R&D intensity 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.67% · OPTIONAL · VALID
SBC intensity 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.68% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 50 states Self-history eligible
Mar 31, 2021 9/9 normalized Level 3 Jun 30, 2021 9/9 normalized Level 3 Sep 30, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 170.33%
Current 209.17%
Delta 38.84% Capex Intensity Increased
Previous 1.63%
Current 1.95%
Delta 0.32% Cash Generation Decreased
Previous 17.29%
Current -22.22%
Delta -39.51% Growth Decreased
Previous 8.57%
Current -6.30%
Delta -14.87% Inventory Pressure Increased
Previous 69.79%
Current 80.10%
Delta 10.31% Margin Decreased
Previous 38.19%
Current 36.00%
Delta -2.19% Profitability Decreased
Previous 15.74%
Current 10.82%
Delta -4.92% R And D Intensity Increased
Previous 3.48%
Current 3.67%
Delta 0.19% Sbc Intensity Increased
Previous 0.67%
Current 0.68%
Delta 0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.